Crystal Research Associates, LLC Issues Executive Informational Overview (EIO) on T3 Motion, Inc.

NEW YORK, NY--(Marketwire - Feb 17, 2012) - Crystal Research Associates, LLC announced today that it has issued an Executive Informational Overview^® (EIO) on T3 Motion, Inc. (NYSE Amex: TTTM). The full 56-page report can be found at www.crystalra.com.

T3 Motion, Inc. engages in the design, manufacturing, and marketing of electric vehicles (EVs), specializing in cost-effective environmentally conscious transportation solutions for professional and consumer markets. First introduced in 2007, the Company's flagship product, the T3 Series stand-up vehicle (ESV), an electric, zero-emission, three-wheel unit, has been associated with an estimated reduction of over 12,000 tons of CO2 emissions and approximate savings of over $9 million in operating costs by its professional customers. T3 Motion also offers two consumer products: (1) the R3 Series prototype, a two-passenger vehicle for the consumer market; and (2) the T3 Series consumer version, the T3 Power Sport.

There are approximately 3,000 T3 Series vehicles in operation across 30 countries. These vehicles are currently used by the Pentagon, CIA and FBI buildings, police departments, cities, municipalities, airports, ports, military bases and installations, the U.S. National Railroad Passenger Corporation (Amtrak), and other venues. The T3 Series ESV has aided security at major events, such as the Tour de France, Rose Parade, Super Bowl, G20 Summit, and Grand Prix Formula One races.

Be the first to hear about Crystal Research's new report releases and upcoming media coverage. Follow us on Twitter at http://twitter.com/crystalresearch or visit http://crystalra.com/blog/ to stay up-to-date on industry and company news for clients under our research coverage.

About Crystal Research Associates, LLC

Crystal Research Associates, LLC is an independent research firm that provides institutional-quality research on small- and mid-cap companies. The firm is led by veteran Wall Street sell-side analyst Jeffrey Kraws, who is well known by the international financial media for his years of work on Wall Street and for providing consistent award-winning analyses and developing long-term relationships on both the buy-side and sell-side. He has been consistently ranked on Wall Street among the Top Ten Analysts for pharmaceutical stock performance in the world for almost two decades as well as ranked as the Number One Stock Picker in the world for pharmaceuticals by Starmine and for estimates from Zacks. Additionally, Mr. Kraws has been 5-Star Ranked for top biotechnology stock performance by Starmine.

Crystal Research Associates' unique and novel product, the Executive Informational Overview® (EIO), is free of investment ratings, target prices, and forward-looking financial models. The EIO presents a crystal clear, detailed report on a company (public or private) in a manner that is easily understood by the Wall Street financial community. The EIO details a company's product/technology/service offerings, market size(s), key intellectual property, leadership, growth strategy, competition, risks, financial statements, key events, and other such fundamental information. Crystal Research Associates has offices in New York City, West Palm Beach, Montréal, and Toronto. Crystal Research Associates has been compensated by the Company in cash of forty-two thousand, five hundred U.S. dollars for its services in creating this report, for updates, and for printing costs.

Forward-Looking Safe Harbor Statement

Statements in this news release regarding future financial and operating results, potential applications of the Company's technology, opportunities for the Company, and any other statements about the future expectations, beliefs, goals, plans, or prospects expressed constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Any statements that are not statements of historical fact (including statements containing the words "will," "believes," "plans," "anticipates," "expects," "estimates," and similar expressions) should also be considered to be forward-looking statements. There are a number of important factors that could cause actual results or events to differ materially from those indicated by such forward-looking statements including, limited operating history, need for future capital, and economic conditions generally. Additional information on potential factors that could affect results and other risks and uncertainties are detailed from time to time in the Company's periodic reports, including forms filed with the SEC.

These statements, and other forward-looking statements, are not guarantees of future performance and involve risks and uncertainties. Crystal Research Associates assumes no obligation to update any of the forward-looking statements in this release.